293 related articles for article (PubMed ID: 8651844)
1. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus.
Ward MM; Pyun E; Studenski S
Arch Intern Med; 1996 Jun; 156(12):1337-44. PubMed ID: 8651844
[TBL] [Abstract][Full Text] [Related]
2. Hospital experience and mortality in patients with systemic lupus erythematosus: which patients benefit most from treatment at highly experienced hospitals?
Ward MM
J Rheumatol; 2002 Jun; 29(6):1198-206. PubMed ID: 12064835
[TBL] [Abstract][Full Text] [Related]
3. Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality.
Ward MM
J Rheumatol; 2000 Jun; 27(6):1408-13. PubMed ID: 10852262
[TBL] [Abstract][Full Text] [Related]
4. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus.
Drenkard C; Villa AR; Alarcón-Segovia D; Pérez-Vázquez ME
J Rheumatol; 1994 Jun; 21(6):1067-72. PubMed ID: 7932417
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis and prognostic indicators of systemic lupus erythematosus in Pakistani patients.
Rabbani MA; Habib HB; Islam M; Ahmad B; Majid S; Saeed W; Shah SM; Ahmad A
Lupus; 2009 Aug; 18(9):848-55. PubMed ID: 19578112
[TBL] [Abstract][Full Text] [Related]
6. Age associated clinical manifestations of systemic lupus erythematosus: a multivariate regression analysis.
Ward MM; Studenski S
J Rheumatol; 1990 Apr; 17(4):476-81. PubMed ID: 2348426
[TBL] [Abstract][Full Text] [Related]
7. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
[TBL] [Abstract][Full Text] [Related]
8. Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality.
Abu-Shakra M; Urowitz MB; Gladman DD; Gough J
J Rheumatol; 1995 Jul; 22(7):1265-70. PubMed ID: 7562756
[TBL] [Abstract][Full Text] [Related]
9. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.
Cook RJ; Gladman DD; Pericak D; Urowitz MB
J Rheumatol; 2000 Aug; 27(8):1892-5. PubMed ID: 10955329
[TBL] [Abstract][Full Text] [Related]
10. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.
Cervera R; Khamashta MA; Font J; Sebastiani GD; Gil A; Lavilla P; Mejía JC; Aydintug AO; Chwalinska-Sadowska H; de Ramón E; Fernández-Nebro A; Galeazzi M; Valen M; Mathieu A; Houssiau F; Caro N; Alba P; Ramos-Casals M; Ingelmo M; Hughes GR;
Medicine (Baltimore); 2003 Sep; 82(5):299-308. PubMed ID: 14530779
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
Mok CC; Lau CS; Wong RW
J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
[TBL] [Abstract][Full Text] [Related]
12. The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: report from two centers.
Pamuk ON; Akbay FG; Dönmez S; Yilmaz N; Calayir GB; Yavuz S
Lupus; 2013 Nov; 22(13):1416-24. PubMed ID: 23929639
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study.
Kwok SK; Ju JH; Cho CS; Kim HY; Park SH
Lupus; 2009 Jan; 18(1):16-21. PubMed ID: 19074164
[TBL] [Abstract][Full Text] [Related]
14. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
15. Systemic lupus erythematosus in the Fars Province of Iran.
Nazarinia MA; Ghaffarpasand F; Shamsdin A; Karimi AA; Abbasi N; Amiri A
Lupus; 2008 Mar; 17(3):221-7. PubMed ID: 18372364
[TBL] [Abstract][Full Text] [Related]
16. Mortality patterns in Malaysian systemic lupus erythematosus patients.
Yeap SS; Chow SK; Manivasagar M; Veerapen K; Wang F
Med J Malaysia; 2001 Sep; 56(3):308-12. PubMed ID: 11732075
[TBL] [Abstract][Full Text] [Related]
17. Familiality and co-occurrence of clinical features of systemic lupus erythematosus.
Tsao BP; Grossman JM; Riemekasten G; Strong N; Kalsi J; Wallace DJ; Chen CJ; Lau CS; Ginzler EM; Goldstein R; Kalunian KC; Harley JB; Arnett FC; Hahn BH; Cantor RM
Arthritis Rheum; 2002 Oct; 46(10):2678-85. PubMed ID: 12384927
[TBL] [Abstract][Full Text] [Related]
18. Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus.
Martínez-Martínez MU; Abud-Mendoza C
Lupus; 2011 May; 20(6):568-74. PubMed ID: 21558137
[TBL] [Abstract][Full Text] [Related]
19. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death.
Abu-Shakra M; Urowitz MB; Gladman DD; Gough J
J Rheumatol; 1995 Jul; 22(7):1259-64. PubMed ID: 7562755
[TBL] [Abstract][Full Text] [Related]
20. Mortality in Malaysians with systemic lupus erythematosus.
Paton NI; Cheong I; Kong NC; Segasothy M
Med J Malaysia; 1996 Dec; 51(4):437-41. PubMed ID: 10968030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
